Research In The R&D Resources Configuration Of Bio-Pharmaceutical Industry In Tianjin

Biological medicine as one of the high-tech industries is the m ost active andfastest field in biological t echnology application progress. It is recognized as one ofthe most promising leading industry in the21st century. In the ea rly1970s, China’ sbiological medicine research and developm ent was been activated by the policy an dcompetitive environment,and then started and de veloped gradually. But the resear chand development resources were lack of in tegration, shared in the low degree, had aserious shortage of funds m eanwhile a lo t of waste. In or der to speed up thedevelopment, make full use of resources, reduce the cost of development and the riskof investment, it is necessa ry to configurate and integrate innovation ef fectively inbiological m edicine i ndustry research-developm ent resources and theresearch-development system, and then im prove the country’ s overall developm entefficiency.The biological industry as m ain of the bi ological medicine is also one of theeight pillar industries and key support strategi c new industry, is also one of the m ostrapid development industry of the high and new technology industry in recent yearsin tianjin. This paper introduces the background, the purpose, significance andmethods of R&D resources configur ation optim ization of T ianjin sBio-Pharmaceutical Ind ustry. Based on R&D data of present bio logical m edicineindustry in T ianjin, through the discuss of the research scope of the definition,investigation index system construction, data analysis of the m odel and the m ethodhow to i mprovement,known the developm ent present situation, th e advantages anddisadvantages of R&D resour ces allocation situation in T ianjin and Im plement KPIanalysis and DEA evaluation.Then found the problem of tianjin biomedicine industryR&D resources allocation, analyze the cau ses, Propose the counterm easures tooptimization tian jin biologica l m edicine industry R&D resources configurationoptimization, improve t he ability of indus try technology from four as pects as thegovernment, enterprises, interm ediary organizations and the united union.The paper provides support to biological medicine industry for tianjin R&D resources allocationsurvey m ethod,provide the basis for the subsequent policy m aking, and providereference of decision for biological m edicine industry R&D resources allocationefficiency optimization of Tianjin.